These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11413742)
1. Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive diffusion and iontophoresis. Fang JY; Sung KC; Hu OY; Chen HY Arzneimittelforschung; 2001; 51(5):408-13. PubMed ID: 11413742 [TBL] [Abstract][Full Text] [Related]
2. The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Huang JF; Sung KC; Hu OY; Wang JJ; Lin YH; Fang JY Int J Pharm; 2005 Jun; 297(1-2):162-71. PubMed ID: 15907603 [TBL] [Abstract][Full Text] [Related]
3. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. Sung KC; Fang JY; Hu OY J Control Release; 2000 Jun; 67(1):1-8. PubMed ID: 10773323 [TBL] [Abstract][Full Text] [Related]
4. The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels. Fang JY; Sung KC; Wang JJ; Chu CC; Chen KT J Pharm Pharmacol; 2002 Oct; 54(10):1329-37. PubMed ID: 12396293 [TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of nalbuphine and its prodrugs by electroporation. Sung KC; Fang JY; Wang JJ; Hu OY Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074 [TBL] [Abstract][Full Text] [Related]
6. A duplex "Gemini" prodrug of naltrexone for transdermal delivery. Hammell DC; Hamad M; Vaddi HK; Crooks PA; Stinchcomb AL J Control Release; 2004 Jun; 97(2):283-90. PubMed ID: 15196755 [TBL] [Abstract][Full Text] [Related]
7. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Nair A; Vyas H; Shah J; Kumar A Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811 [TBL] [Abstract][Full Text] [Related]
8. Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies. Liu FI; Kuo JH; Sung KC; Hu OY Int J Pharm; 2003 May; 257(1-2):23-31. PubMed ID: 12711158 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist. Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639 [TBL] [Abstract][Full Text] [Related]
10. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl. Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964 [TBL] [Abstract][Full Text] [Related]
11. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Fang JY; Sung KC; Lin HH; Fang CL Int J Pharm; 1999 Feb; 178(1):83-92. PubMed ID: 10205628 [TBL] [Abstract][Full Text] [Related]
12. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. Nolan LM; Corish J; Corrigan OI; Fitzpatrick D Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. Fang JY; Hsu LR; Huang YB; Tsai YH Int J Pharm; 1999 Apr; 180(2):137-49. PubMed ID: 10370184 [TBL] [Abstract][Full Text] [Related]
15. Effect of iontophoresis on in vitro transdermal absorption of almotriptan. Calatayud-Pascual MA; Balaguer-Fernández C; Serna-Jiménez CE; Del Rio-Sancho S; Femenía-Font A; Merino V; López-Castellano A Int J Pharm; 2011 Sep; 416(1):189-94. PubMed ID: 21736929 [TBL] [Abstract][Full Text] [Related]
16. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis. Anroop B; Ghosh B; Parcha V; Khanam J Curr Drug Deliv; 2009 Jul; 6(3):280-90. PubMed ID: 19604142 [TBL] [Abstract][Full Text] [Related]
17. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin. Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950 [TBL] [Abstract][Full Text] [Related]
18. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. Wang JJ; Sung KC; Hu OY; Yeh CH; Fang JY J Control Release; 2006 Oct; 115(2):140-9. PubMed ID: 16959357 [TBL] [Abstract][Full Text] [Related]